Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
LAMC1 transcript levels were higher in high-grade than those in low-grade endometrioid carcinoma.
»
07/30/15
Methylation-associated Silencing of microRNA-126 and its Host Gene EGFL7 in Malignant Pleural Mesothelioma.
The EGFL7 promoter region was hypermethylated.
»
10/28/15
Olfactory receptor family receptor, family 7, subfamily C, member 1 is a novel marker of colon cancer-initiating cells and is a potent target of immunotherapy.
OR7C1-derived antigenic peptide-specific cytotoxic T lymphocytes (CTLs) showed specific cytotoxicity for cancer-initiating cells.
»
02/11/16
DESC1, a novel tumor suppressor, sensitizes cells to apoptosis by down-regulating the EGFR/AKT pathway in esophageal squamous cell carcinoma.
DESC1 reduced tumor growth kinetics in the in vivo orthotopic tumorigenesis assay.
»
09/17/15
Impact of Body Weight Loss on Recurrence After Curative Gastrectomy for Gastric Cancer.
Postoperative BWL was significantly higher in patients with tumours in the upper stomach.
»
02/07/16
Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1.
SChLAP1 was overexpressed in bladder cancer tissues compared to paired normal bladder tissues.
»
01/12/16
Therapeutic silencing of HPV 16 E7 by systemic administration of siRNA-neutral DOPC nanoliposome in a murine cervical cancer model with obesity.
No negative impact of obesity on the antitumor activity of siRNA-DOPC-NP in obese mice.
»
02/09/16
Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor positive breast cancer (ANZ0501 LATER): An open-label randomised controlled trial.
Emerging data supporting longer duration endocrine therapy for hormone receptor positive breast cancer.
»
02/11/16
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7.
YB-1 signaling regulated AR V7 expression, and YB-1 inhibition.
»
07/14/15
High PTPRQ Expression and Its Relationship to Expression of PTPRZ1 and the Presence of KRAS Mutations in Colorectal Cancer Tissues.
Support for hypothesis that PTPRQ is a candidate oncogene.
»
02/07/16
< Prev
Next >